Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor
Conditions: Acute Kidney Injury Interventions: Drug: Pantoprazole; Drug: Famotidine Sponsors: The University of Texas Health Science Center, Houston; Society of Cardiovascular Anesthesiologists Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI
Conditions: Cardiovascular Diseases Interventions: Drug: cardiomyopeptidin Sponsors: Chinese PLA General Hospital; Dalian Zhen-Ao Bio-Tech Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
Conditions: Cardiac Disease; Cardiac Ischemia; Cardiac Valve Disease Interventions: Procedure: Open heart surgery group.; Procedure: Percutaneous cardiovascular surgery group. Sponsors: Hospital Israelita Albert Einstein Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring
Conditions: Cardiovascular Diseases; Heart Disease Risk Factors Interventions: Behavioral: Observational Group Sponsors: The University of Texas at Arlington; American Heart Association Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Treatment of Atrial Fibrillation in the Community Settings
Conditions: Atrial Arrhythmia; Cardiovascular Diseases Interventions: Procedure: Direct current cardioversion Sponsors: ITMO University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Conditions: Chronic Lymphocytic Leukemia; Hematopoietic and Lymphoid System Neoplasm; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Mindfulness App Training for Cardiovascular Health
Conditions: Cardiovascular Diseases; Mindfulness Interventions: Behavioral: Mindfulness Training; Behavioral: Enhanced Usual Care Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Effects of Static Apnea at High Lung Volume on Hypoalgesia, Cardiovascular Function and Respiratory Function
Conditions: Pain; Hypoxia; Hypercapnia; Apnea Interventions: Other: Voluntary apnoea Sponsors: Centro Universitario La Salle Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Conditions: Coarctation of Aorta; High Blood Pressure Interventions: Drug: Losartan; Drug: Amlodipine; Drug: Placebo Sponsors: Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Conditions: Chronic Limb-Threatening Ischemia Interventions: Device: Shockwave Medical IVL System Sponsors: Cardiovascular and Interventional Radiological Society of Europe; Shockwave Medical, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}
This study is being performed as a randomized, multicenter, open-label, parallel-group, clinical trial in which 720 participants are to undergo 24-h ambulatory blood pressure measurement (ABPM) and office blood pressure measurement (OBPM) at baseline before being randomly assigned to a morning (6 –10 am) or a bedtime (6–10 pm) administration group. Each participant receives one 20/5-mg tablet of olmesartan/amlodipine (OA) daily for 4 weeks and is then followed up at 4-week intervals for a total of 12 weeks. During follow-up, the OA dosage is adjusted according to the ABPM and OBPM result s. Patients with uncontrolled h...
Source: Trials - November 28, 2023 Category: Research Source Type: clinical trials
Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
Conditions: Nephropathy; Diabetic Nephropathies; Diabetes Mellitus, Type 1; Albuminuria; Diabetic Complications Renal; Diabetic Complications Cardiovascular; Hypoxia Interventions: Drug: Sotagliflozin; Drug: Placebo Sponsors: Steno Diabetes Center Copenhagen; Juvenile Diabetes Research Foundation; King ' s College London; Glostrup University Hospital, Copenhagen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
The Impact of a Personalized Care Intervention on 90-day Post-Discharge Care
Conditions: Readmissions in Cardiovascular Disorders Interventions: Behavioral: Laguna Coach and App Intervention Group Sponsors: Laguna Health, Inc; Mayo Clinic Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
The Diagnosis and Treatment Pattern of CKD in Patients With Cardiovascular Disease- a National Cross-sectional Study
Conditions: Renal Insufficiency, Chronic; Cardiovascular Diseases; Diagnosis Sponsors: Guangdong Provincial People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
Conditions: Cardiovascular Diseases; Cardiovascular Disease Prevention Interventions: Behavioral: community pharmacist intervention Sponsors: University Ghent; University Hospital, Ghent; Vrije Universiteit Brussel; Universit é de Liège Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
